Soft tissue regeneration company, Aroa Biosurgery, is set to list on the ASX at the end of the month. The company is looking to raise $45m at an offer price of $0.75, ultimately giving the Auckland-based company a proposed market capitalisation of $225m. Aroa’s technology is centred around soft tissue regeneration and the complex wound
Read More
The coronavirus has pulled the plug on many proposed initial public offers (IPOs), with the Australian Securities Exchange’s ‘upcoming listings’ feed looking decidedly barren. But some promoters are quietly forging ahead, in the sectors that have been largely impervious to – or have benefit from – the COVID-19 mayhem. We’re talking about resources (especially gold),
Read More